Variables | ccCoV | Influenza | P valuea |
---|---|---|---|
N = 205 (%) | N = 417 (%) | ||
Gender | 0.498 | ||
Male | 88 (42.9) | 191 (45.8) | |
Female | 117 (57.1) | 226 (54.2) | |
Ethnicity | 0.002* | ||
Malay | 62 (30.2) | 176 (42.2) | |
Chinese | 69 (33.7) | 87 (20.9) | |
Indian | 69 (33.7) | 136 (32.6) | |
Others | 5 (2.4) | 18 (4.3) | |
Age, years, mean (range) | 49.1 (11–81) | 42.1 (7–91) | < 0.0001* |
0–18 | 5 (2.4) | 38 (9.1) | |
19–54 | 106 (51.7) | 251 (60.2) | |
≥ 55 | 94 (45.9) | 128 (30.7) | |
Presence of baseline comorbidities | 0.522 | ||
None | 84 (41.0) | 183 (43.9) | |
Yes | 120 (58.5) | 234 (56.1) | |
Number of baseline comorbidities | 0.838 | ||
1 | 43 (35.8) | 88 (37.6) | |
2 | 40 (33.4) | 70 (29.9) | |
≥ 3 | 37 (30.8) | 76 (32.5) | |
Baseline comorbidities | |||
Hypertension | 83 (40.5) | 110 (26.4) | < 0.0001* |
Dyslipidemia | 49 (23.9) | 72 (17.3) | 0.052 |
Diabetes mellitus | 37 (18.0) | 85 (20.4) | 0.521 |
Ischemic heart disease | 15 (7.3) | 34 (8.2) | 0.755 |
Asthma | 12 (5.9) | 40 (9.6) | 0.126 |
Malignancy | 7 (3.4) | 20 (4.8) | 0.532 |
Allergic rhinitis | 5 (2.4) | 31 (7.4) | 0.016* |
Other endocrine disease | 5 (2.4) | 10 (2.4) | 1 |
Chronic renal failure | 3 (1.5) | 7 (1.7) | 1 |
Chronic obstructive pulmonary disease | 2 (1.0) | 1 (0.2) | 0.252 |
Obesity | 1 (0.5) | 16 (3.8) | 0.016* |
Autoimmune disease | 0 (0) | 12 (2.9) | 0.011* |
Smoking status | 0.46 | ||
Non-smoker | 194 (94.6) | 392 (94.0) | |
Smoker | 9 (4.4) | 25 (6.0) | |
Clinical symptoms | |||
Fever | 96 (46.8) | 346 (83.0) | < 0.0001* |
Cough | 176 (85.9) | 353 (84.7) | 0.116 |
Sore throat | 148 (72.2) | 186 (44.6) | < 0.0001* |
Hoarseness of voice | 138 (67.3) | 16 (3.8) | < 0.0001* |
Nasal congestion | 124 (60.5) | 165 (39.6) | < 0.0001* |
Nasal discharge | 174 (84.9) | 246 (59.0) | < 0.0001* |
Sneezing | 145 (70.7) | 60 (14.4) | < 0.0001* |
Headache | 116 (56.6) | 41 (9.8) | < 0.0001* |
Myalgia | 118 (57.6) | 81 (19.4) | < 0.0001* |
Total symptom severity scoreb | 0.001* | ||
Mild | 83 (40.5) | 112 (26.9) | |
Moderate | 102 (49.8) | 234 (56.1) | |
Severe | 20 (9.8) | 71 (17.0) |